Eledon Pharmaceuticals (ELDN) Prepaid Assets (2013 - 2026)
Eledon Pharmaceuticals' (ELDN) quarterly Prepaid Assets came in at $2.5 million in Q1 2026, up 4418.18% YoY from $55000.0 in Q1 2025, and up 1024.43% on a QoQ basis from $221000.0 in Q4 2025.
Analysis
Eledon Pharmaceuticals (ELDN) Prepaid Assets (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals (ELDN) has 14 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.
- Quarterly Prepaid Assets rose 4418.18% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 4418.18% YoY) and the FY2025 annual result came in at $221000.0, down 93.78% from the prior year.
- Prepaid Assets climbed to $2.5 million in Q1 2026, from $221000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.1 million in Q1 2024 to a low of $10000.0 in Q2 2025.
- A 5-year average of $1.4 million and a median of $287000.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 10782.98% — and 2025, when it slumped 98.92%.
- Tracing ELDN's Prepaid Assets over 5 years: stood at $3.1 million in 2022, then tumbled by 94.05% to $185000.0 in 2023, then soared by 1820.0% to $3.6 million in 2024, then sank by 93.78% to $221000.0 in 2025, then surged by 1024.43% to $2.5 million in 2026.
- The last three Prepaid Assets figures came in at $2.5 million (Q1 2026), $221000.0 (Q4 2025), and $248000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Eledon Pharmaceuticals | 344.87 Mn | 344.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.34 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Sep 30, 2025 | 2.90 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Mar 31, 2025 | 2.84 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 3.61 Mn |
| Mar 31, 2024 | 5.12 Mn |
| Dec 31, 2023 | 5.03 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 2.42 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 1.68 Mn |
| Jun 30, 2022 | 2.33 Mn |
| Mar 31, 2022 | 2.65 Mn |
| Dec 31, 2021 | 3.51 Mn |
| Sep 30, 2021 | 1.52 Mn |